Processa Pharmaceuticals (PCSA) Short Interest Ratio & Short Volume $0.39 0.00 (-0.26%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.40 +0.02 (+3.86%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Processa Pharmaceuticals Short Interest DataProcessa Pharmaceuticals (PCSA) has a short interest of 95,300 shares, representing 2.08% of the float (the number of shares available for trading by the public). This marks a -28.45% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 768,874 shares to cover all short positions.Current Short Interest95,300 sharesPrevious Short Interest133,200 sharesChange Vs. Previous Month-28.45%Dollar Volume Sold Short$42,599.10Short Interest Ratio0.4 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares3,267,000 sharesFloat Size4,590,000 sharesShort Percent of Float2.08%Today's Trading Volume48,387 sharesAverage Trading Volume768,874 sharesToday's Volume Vs. Average6% Short Selling Processa Pharmaceuticals? Sign up to receive the latest short interest report for Processa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCSA Short Interest Over TimePCSA Days to Cover Over TimePCSA Percentage of Float Shorted Over Time Remove Ads Processa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202595,300 shares $42,599.10 -28.5%2.1%0.4 $0.45 2/28/2025133,200 shares $73,126.80 -43.6%3.4%0.3 $0.55 2/15/2025236,200 shares $141,956.20 -74.3%6.0%0.5 $0.60 1/31/2025920,400 shares $598,260.00 +965.3%23.2%2 $0.65 1/15/202586,400 shares $75,159.36 -27.8%2.6%0.3 $0.87 12/31/2024119,600 shares $105,702.48 -64.1%3.7%0.4 $0.88 12/15/2024333,200 shares $369,852.00 +365.4%10.2%1 $1.11 11/30/202471,600 shares $82,769.60 -2.1%2.5%0.2 $1.16 11/15/202473,100 shares $73,823.69 -25.0%2.5%1.1 $1.01 10/31/202497,400 shares $112,497.00 -40.5%3.4%1.3 $1.16 Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024163,600 shares $202,864.00 +164.3%5.7%0.2 $1.24 9/30/202461,900 shares $84,803.00 -16.1%2.1%0.1 $1.37 9/15/202473,800 shares $98,892.00 -24.2%2.6%0.1 $1.34 8/31/202497,300 shares $134,274.00 -7.2%3.4%0.1 $1.38 8/15/2024104,800 shares $137,288.00 -88.9%3.7%0.1 $1.31 7/31/2024942,300 shares $1.98 million +1,834.9%38.0%0.9 $2.10 7/15/202448,700 shares $84,738.00 -28.8%1.9%0 $1.74 6/30/202468,400 shares $153,216.00 -51.9%2.7%0.1 $2.24 6/15/2024142,200 shares $248,850.00 +532.0%5.7%0.1 $1.75 5/31/202422,500 shares $33,300.00 -52.6%0.9%0 $1.48 5/15/202447,500 shares $95,950.00 -91.6%1.9%0 $2.02 4/30/2024568,300 shares $1.24 million +199.7%24.8%0.4 $2.18 4/15/2024189,600 shares $287,244.00 +429.6%8.3%0.1 $1.52 3/31/202435,800 shares $84,667.00 -11.2%1.6%0 $2.37 3/15/202440,300 shares $88,257.00 -40.1%2.9%0 $2.19 2/29/202467,300 shares $165,558.00 -29.7%5.4%0 $2.46 2/15/202495,700 shares $232,551.00 -41.0%7.7%0.1 $2.43 1/31/2024162,100 shares $382,556.00 +1,721.4%12.5%0.1 $2.36 1/15/20248,900 shares $46,796.20 -98.0%0.7%0.1 $5.26 12/31/2023443,300 shares $148,328.18 +46.3%N/A0.2 $0.33 12/15/2023303,000 shares $216,645.00 -17.6%N/A0.1 $0.72 11/30/2023367,800 shares $235,392.00 +55.1%N/A0.2 $0.64 11/15/2023237,200 shares $93,456.80 +13.6%N/A0.1 $0.39 10/31/2023208,900 shares $73,323.90 +13.0%N/A0.1 $0.35 10/15/2023184,800 shares $88,704.00 +43.4%N/A0.1 $0.48 9/30/2023128,900 shares $32,250.78 -6.7%N/A1.2 $0.25 9/15/2023138,100 shares $53,168.50 +14.9%N/A1.8 $0.39 8/31/2023120,200 shares $37,742.80 +31.8%N/A1 $0.31 8/15/202391,200 shares $34,656.00 +11.6%N/A0.8 $0.38 7/31/202381,700 shares $35,948.00 -6.6%N/A0.7 $0.44Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/15/202387,500 shares $40,512.50 -28.7%N/A0.7 $0.46 6/30/2023122,700 shares $61,043.25 -32.6%N/A1 $0.50 6/15/2023182,000 shares $109,200.00 -9.6%N/A1.6 $0.60 5/31/2023201,300 shares $124,806.00 +3.2%N/A2.3 $0.62 5/15/2023195,000 shares $128,505.00 +0.5%N/A2.1 $0.66 4/30/2023194,000 shares $122,220.00 +18.7%N/A1.6 $0.63 4/15/2023163,500 shares $81,750.00 -12.3%N/A0.6 $0.50 3/31/2023186,400 shares $93,218.64 -41.7%N/A0.7 $0.50 3/15/2023319,700 shares $164,325.80 -14.3%N/A1.2 $0.51 2/28/2023372,900 shares $249,805.71 -15.8%N/A1.4 $0.67 2/15/2023442,800 shares $352,026.00 +94.5%N/A1.7 $0.80 1/31/2023227,700 shares $194,683.50 -1.6%2.0%0.9 $0.86 1/15/2023231,500 shares $289,375.00 -9.3%2.0%5.2 $1.25 12/30/2022255,300 shares $280,830.00 +124.7%2.2%6.3 $1.10 12/15/2022113,600 shares $214,704.00 +38.4%1.0%3 $1.89 11/30/202282,100 shares $155,948.95 +11.7%0.7%4.3 $1.90 11/15/202273,500 shares $151,410.00 -5.3%0.7%4.3 $2.06 10/31/202277,600 shares $164,512.00 +7.0%0.7%5.5 $2.12 10/15/202272,500 shares $160,950.00 -13.3%0.7%5.6 $2.22 9/30/202283,600 shares $188,936.00 +27.3%0.8%6.6 $2.26 9/15/202265,700 shares $170,820.00 +0.2%0.6%4.6 $2.60 8/31/202265,600 shares $180,400.00 -4.8%0.6%4.5 $2.75 8/15/202268,900 shares $224,614.00 -4.8%0.6%4.3 $3.26 7/31/202272,400 shares $224,440.00 -17.6%0.6%2.9 $3.10 7/15/202287,900 shares $296,776.77 -15.3%0.8%3.2 $3.38 6/30/2022103,800 shares $291,678.00 -5.3%0.9%3.3 $2.81 6/15/2022109,600 shares $283,864.00 -11.3%0.9%3.6 $2.59 5/31/2022123,500 shares $314,925.00 +31.9%1.1%3.6 $2.55 5/15/202293,600 shares $169,416.00 +19.7%0.8%2.8 $1.81 4/30/202278,200 shares $216,614.00 +8.0%0.7%2.6 $2.77 4/15/202272,400 shares $230,956.00 -9.1%0.6%2.2 $3.19 3/31/202279,600 shares $239,596.00 -21.2%0.7%2.5 $3.01 3/15/2022101,000 shares $349,460.00 +8.6%0.9%3 $3.46 2/28/202293,000 shares $356,190.00 -18.6%0.8%2.6 $3.83 2/15/2022114,300 shares $417,195.00 -5.4%1.0%2.9 $3.65 1/31/2022120,800 shares $446,960.00 +5.1%3.0%2.8 $3.70 1/15/2022114,900 shares $499,815.00 +18.5%2.8%2.6 $4.35 12/31/202197,000 shares $475,300.00 +11.9%2.4%2.2 $4.90 12/15/202186,700 shares $362,406.00 +7.4%2.1%1.7 $4.18 11/30/202180,700 shares $440,622.00 -11.8%2.0%1.5 $5.46 11/15/202191,500 shares $589,260.00 -2.5%2.3%1.5 $6.44 10/29/202193,800 shares $649,096.00 -16.4%2.3%1.6 $6.92 10/15/2021112,200 shares $879,648.00 +4.7%2.8%1.1 $7.84 9/30/2021107,200 shares $918,704.00 +15.4%2.6%1.1 $8.57 9/15/202192,900 shares $690,247.00 +17.6%2.3%1 $7.43 8/31/202179,000 shares $515,080.00 -4.9%2.2%0.8 $6.52 8/13/202183,100 shares $449,571.00 -28.7%2.3%0.9 $5.41 7/30/2021116,500 shares $696,670.00 -8.6%3.3%1.3 $5.98 7/15/2021127,500 shares $860,625.00 -7.9%3.6%2.6 $6.75 6/30/2021138,400 shares $1.13 million +107.8%3.9%2.6 $8.19Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 6/15/202166,600 shares $442,890.00 +8.1%1.9%0.9 $6.65 5/28/202161,600 shares $378,840.00 -8.1%1.7%0.9 $6.15 5/14/202167,000 shares $412,720.00 -8.7%1.9%0.9 $6.16 4/30/202173,400 shares $616,560.00 +15.2%2.1%0.8 $8.40 4/15/202163,700 shares $596,232.00 +17.7%1.5%0.8 $9.36 3/31/202154,100 shares $590,231.00 +21.0%1.5%0.7 $10.91 3/15/202144,700 shares $518,520.00 +329.8%1.3%0.7 $11.60 2/26/202110,400 shares $110,968.00 -14.1%0.3%0.2 $10.67 2/12/202112,100 shares $95,590.00 +157.5%0.3%0.2 $7.90 1/29/20214,700 shares $29,187.00 -44.1%0.1%0.1 $6.21 1/15/20218,400 shares $57,456.00 No Change0.2%0.3 $6.84 9/30/2020100 shares $900.00 No ChangeN/A0 $9.00 PCSA Short Interest - Frequently Asked Questions What is Processa Pharmaceuticals' current short interest? Short interest is the volume of Processa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 95,300 shares of PCSA short. 2.08% of Processa Pharmaceuticals' shares are currently sold short. Learn More on Processa Pharmaceuticals' current short interest. What is a good short interest percentage for Processa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.08% of Processa Pharmaceuticals' floating shares are currently sold short. Is Processa Pharmaceuticals' short interest increasing or decreasing? Processa Pharmaceuticals saw a decrease in short interest in March. As of March 15th, there was short interest totaling 95,300 shares, a decrease of 28.5% from the previous total of 133,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Processa Pharmaceuticals' float size? Processa Pharmaceuticals currently has issued a total of 3,267,000 shares. Some of Processa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Processa Pharmaceuticals currently has a public float of 4,590,000 shares. How does Processa Pharmaceuticals' short interest compare to its competitors? 2.08% of Processa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Processa Pharmaceuticals: NLS Pharmaceutics Ltd. (2.66%), Sonoma Pharmaceuticals, Inc. (14.21%), Ensysce Biosciences, Inc. (1.83%), Organovo Holdings, Inc. (3.31%), Kazia Therapeutics Limited (2.32%), Clearmind Medicine Inc. (6.53%), Adial Pharmaceuticals, Inc. (8.50%), Aptorum Group Limited (0.96%), Creative Medical Technology Holdings, Inc. (1.46%), Allarity Therapeutics, Inc. (14.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Processa Pharmaceuticals stock? Short selling PCSA is an investing strategy that aims to generate trading profit from Processa Pharmaceuticals as its price is falling. PCSA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Processa Pharmaceuticals? A short squeeze for Processa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PCSA, which in turn drives the price of the stock up even further. How often is Processa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCSA, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies NLSP Short Squeeze SNOA Short Squeeze ENSC Short Squeeze ONVO Short Squeeze KZIA Short Squeeze CMND Short Squeeze ADIL Short Squeeze APM Short Squeeze CELZ Short Squeeze ALLR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCSA) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
